The production of proteinases is encoded by a family of 10 genes known as

SAP, which are distributed differently among the species. The expression of these genes may be influenced by environmental conditions, which generally result in a higher fungal invasive potential. Non-pathogenic Candida spp. usually have fewer SAP genes, which Ibrutinib are not necessarily expressed in the genome. Exposure to subinhibitory concentrations of antifungal agents promotes the development of resistant strains with an increased expression of SAP genes. In general, Candida spp. isolates that are resistant to antifungals show a higher secretion of Sap than the susceptible isolates. The relationship between Sap secretion and the susceptibility profile of the isolates is of great interest, although

the role of SAPs in the development of resistance to antifungal agents remains still unclear. This review is the first one to address these issues. The relationship between Candida spp. infections and the hospital environment gained importance in the 1980s where it was linked to the advancement of medical scientific technology, a better understanding of the mechanisms that trigger disease, and the mechanisms that offer increased survival in patients with terminal illnesses that die from fungal infections and not from the underlying disease.[1-3] It is thought that the rise in the incidence of these infections is associated with antimicrobial resistance and the restricted number of available antifungal drugs.[4] selleck Infections caused by Candida spp. represent a serious public health

problem. Candida albicans is considered the main species.[5] An analysis conducted by Tortorano et al. [6] in Europe showed that more than half of all cases of candidemia are caused by C. albicans, whereas among the non-albicans Candida spp., the incidence of Cyclic nucleotide phosphodiesterase C. glabrata and C. parapsilosis is 14% and the incidence of C. tropicalis is 7%. An observational study on 23 North American medical centres reported predominantly the presence of non-albicans Candida spp. (54.4%); however, C. albicans was the most isolated species (45.6%).[7] In Chile, Ajenjo et al. [8] observed a progressive increase in infections caused by non-albicans Candida spp. and C. parapsilosis was the most frequent species, followed by C. tropicalis and C. glabrata. Cornistein et al. [9] conducted an epidemiologic study at a neurological centre in Buenos Aires between 2006 and 2010 where they observed that 43.3% of all clinical specimens were C. albicans, while 56.7% were non-albicans Candida spp. An epidemiological study conducted by Colombo et al. [10], which involved the evaluation of the incidence of nosocomial infections in 11 health centres in Brazil, found a high incidence of candidemia, with Candida spp. being the fourth most frequently isolated pathogens, preceded only by coagulase-negative staphylococci, Staphylococcus aureus, and Klebsiellla pneumoniae. In this study, the most commonly isolated Candida species was C.